A Open Randomized Clinical Trial Comparing the Efficacy and Safety of Clevudine 30mg Versus Adefovir 10mg in Patients With LC-B [liver cirrhosis B].

Trial Profile

A Open Randomized Clinical Trial Comparing the Efficacy and Safety of Clevudine 30mg Versus Adefovir 10mg in Patients With LC-B [liver cirrhosis B].

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Dec 2014

At a glance

  • Drugs Clevudine (Primary) ; Adefovir
  • Indications Hepatitis B
  • Focus Registrational; Therapeutic Use
  • Sponsors Bukwang Pharmaceutical
  • Most Recent Events

    • 17 Dec 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 25 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 27 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top